Sygnature Discovery
Sygnature Discovery, a leading integrated drug discovery CRO, offers a range of services across medicinal and computational chemistry, in vitro and in vivo pharmacology as well as DMPK. Since 2011, 30 compounds discovered by Sygnature have entered pre-clinical development; so far, 15 of these have progressed to clinical trials.
www.sygnaturediscovery.com
Видео Sygnature Discovery канала Sygnature Discovery
www.sygnaturediscovery.com
Видео Sygnature Discovery канала Sygnature Discovery
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Insights from Sygnature Discovery's CEO - Find out more about Sygnature Discovery#MitochondriaUnlocked_How kinetics experiments unveil the complexities of this organelle (Part 3/5)Sygnature Discovery - Integrated Drug Discovery CRO#MitochondriaUnlocked_Measuring the dynamics and biogenesis in different modelsA New Discovery - Sygnature Discovery becomes a transatlantic CROChemistry: Joining The DepartmentA look inside Sygnature DiscoveryInsights from Sygnature Discovery's CE0 - Significance of recent acquisitions#MitochondriaUnlocked_ The pursuit of mitochondrial function for large pharma & biotech (Part 1/5)Alderley Park Directors Series - BioscienceInsights from Sygnature Discovery's CEO - What makes Sygnature Discovery a great place to work?Alderley Park Directors Series - ChemistrySygnature Discovery on BBC NewsCHARMED_Fast, combinatorial degrader discovery from Sygnature DiscoveryWorking at Sygnature DiscoveryAlderley Park Directors Series - DMPKInsights from Sygnature Discovery's CEO - Industry#MitochondriaUnlocked_Tatiana's conclusions on mitochondria in drug developmentWorking With Sygnature - Amy ProsserANewDiscovery - Becoming a cross-Atlantic CRO